Elizabeth Holmes — Theranos Fraud

Elizabeth Anne Holmes was the founder and CEO of Theranos, a health technology company that claimed to have developed revolutionary blood testing technology capable of running hundreds of tests from a single drop of blood obtained through a finger prick. [At its peak in 2013-2014, Theranos was valued at approximately 9 billion dollars, and Holmes was celebrated as the youngest self-made female billionaire in America](https://www.vox.com/recode/2019/5/8/18533975/theranos-elizabeth-holmes-fraud-explained). The company's technology, however, did not work as claimed, and Holmes was convicted of fraud for deceiving investors about the capabilities and reliability of the company's blood testing devices.

Holmes was born on February 3, 1984, in Washington, D.C., and grew up in Houston, Texas. She enrolled at Stanford University in 2002, studying chemical engineering, but dropped out at age 19 to found Real-Time Cures, which was later renamed Theranos. Holmes modeled herself explicitly on Steve Jobs, adopting a signature wardrobe of black turtlenecks and cultivating an unusually deep voice. She assembled a board of directors that included former Secretary of State Henry Kissinger, former Secretary of Defense James Mattis, and former Secretary of State George Shultz, lending the company an aura of legitimacy that attracted both investment and media attention.

Theranos's core product was a device called the Edison, which Holmes claimed could perform a wide range of blood tests — from cholesterol to cancer markers — using just a few drops of blood from a finger prick, at a fraction of the cost of conventional lab testing. The company secured partnerships with Walgreens, which opened Theranos testing centers in its stores, and with the U.S. Department of Defense.

In reality, the Edison devices were unreliable and produced inaccurate results. Internal employees raised concerns about the technology's accuracy, but Holmes and her boyfriend and business partner, Ramesh "Sunny" Balwani, silenced dissent through intimidation, non-disclosure agreements, and termination. When the Edison could not produce reliable results, Theranos secretly used conventional testing machines to process the majority of its tests.

[The unraveling began with investigative reporting by John Carreyrou of The Wall Street Journal, who published the first of a series of articles in October 2015 exposing the discrepancy between Theranos's claims and its actual capabilities](https://www.wsj.com/articles/theranos-has-struggled-with-blood-tests-1444881901). Carreyrou's reporting, based in part on information from whistleblowers including Tyler Shultz and Erika Cheung, revealed that Theranos was running most tests on conventional machines, that its proprietary technology produced inaccurate results, and that patient health had been endangered by unreliable test results.

[Following the Journal's exposé, federal regulators moved swiftly. The Centers for Medicare and Medicaid Services found serious deficiencies in Theranos's lab and revoked its CLIA certificate, effectively banning Holmes from operating a lab for two years](https://www.washingtonpost.com/technology/2022/01/03/elizabeth-holmes-trial-verdict/). The SEC charged Holmes with massive fraud in March 2018, resulting in a settlement where she relinquished control of Theranos and paid a ,000 fine. In June 2018, a federal grand jury indicted both Holmes and Balwani on multiple counts of wire fraud and conspiracy to commit wire fraud. Theranos officially dissolved in September 2018.

Following the Journal's reporting, the Centers for Medicare and Medicaid Services inspected Theranos's laboratory in Newark, California, and found serious deficiencies that posed "immediate jeopardy to patient health and safety." Theranos voided two years of test results and was banned from operating a laboratory.

[Holmes was charged by the Securities and Exchange Commission in March 2018 with massive fraud and settled the civil charges](https://www.washingtonpost.com/technology/2022/01/03/elizabeth-holmes-trial-verdict/), agreeing to pay a 500,000-dollar fine and relinquish voting control of Theranos. The company formally dissolved in September 2018.

In June 2018, a federal grand jury indicted Holmes and Balwani on multiple counts of wire fraud and conspiracy to commit wire fraud. Holmes's trial began on September 8, 2021, in the U.S. District Court for the Northern District of California before Judge Edward Davila.

Holmes testified in her own defense, claiming that she genuinely believed in the technology and that she had been subject to psychological and sexual abuse by Balwani. The prosecution argued that Holmes knowingly deceived investors and endangered patients.

[On January 3, 2022, the jury found Holmes guilty of four counts of wire fraud — specifically, defrauding investors — and not guilty of four counts related to defrauding patients](https://www.cnn.com/2022/01/03/tech/elizabeth-holmes-verdict/index.html). [On November 18, 2022, Judge Davila sentenced Holmes to 11 years and 3 months in federal prison](https://www.npr.org/2022/11/18/1137683813/elizabeth-holmes-sentenced-theranos).

Sunny Balwani was tried separately and convicted of all twelve counts of fraud. He was sentenced to nearly 13 years in prison.

[Holmes reported to a minimum-security federal prison camp in Bryan, Texas, on May 30, 2023](https://www.bbc.com/news/technology-66476521). She is projected to be released in 2032.